Psyence Biomedical Ltd. (PBM)
NASDAQ: PBM · Real-Time Price · USD
1.760
-0.050 (-2.76%)
At close: Dec 5, 2025, 4:00 PM EST
1.710
-0.050 (-2.84%)
After-hours: Dec 5, 2025, 7:50 PM EST
Psyence Biomedical Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
| TTM
| FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| Net Income | -3.94 | 1.01 | -51.16 | -3.21 | -1.86 |
| Depreciation & Amortization | 0.01 | 0 | 0 | - | - |
| Stock-Based Compensation | 0.03 | - | 0.32 | 0.22 | 0.33 |
| Other Operating Activities | 0.45 | -4.36 | 49.07 | -0.08 | - |
| Change in Accounts Receivable | -0.05 | -0.1 | 0.11 | -0.11 | 0.1 |
| Change in Accounts Payable | -0.21 | -0.36 | -1.04 | 1.66 | 0.03 |
| Change in Other Net Operating Assets | -0.1 | 0.07 | -0.25 | -0.07 | 0 |
| Operating Cash Flow | -4.25 | -3.73 | -2.95 | -1.59 | -1.4 |
| Capital Expenditures | -0 | -0.01 | -0.01 | - | - |
| Other Investing Activities | -0.02 | -0.01 | - | - | -0.03 |
| Investing Cash Flow | -4.02 | -0.02 | -0.01 | - | -0.03 |
| Short-Term Debt Issued | - | 1 | 2.5 | - | - |
| Total Debt Issued | - | 1 | 2.5 | - | - |
| Short-Term Debt Repaid | - | - | -0.15 | - | - |
| Total Debt Repaid | - | - | -0.15 | - | - |
| Net Debt Issued (Repaid) | - | 1 | 2.35 | - | - |
| Issuance of Common Stock | 1.74 | 1.74 | - | - | - |
| Other Financing Activities | 11.74 | 6.41 | - | 1.17 | -1.63 |
| Financing Cash Flow | 13.49 | 9.15 | 2.35 | 1.17 | -1.63 |
| Net Cash Flow | 5.22 | 5.4 | -0.6 | -0.42 | -3.06 |
| Free Cash Flow | -4.25 | -3.74 | -2.95 | -1.59 | -1.4 |
| Free Cash Flow Per Share | -6.00 | -19.39 | -270.67 | - | - |
| Levered Free Cash Flow | -4.01 | -3.39 | -1.71 | -0.32 | - |
| Unlevered Free Cash Flow | -4 | -3.39 | -1.68 | -0.32 | - |
| Change in Working Capital | -0.36 | -0.39 | -1.17 | 1.48 | 0.13 |
Source: S&P Capital IQ. Standard template.
Financial Sources.